[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Page 50378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21701]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This meeting is open to the 
public, is limited only by room seating available, (120). The public is 
also welcome to listen to the meeting via teleconference at 800-857-
9838, passcode: 5325685; 100 teleconference lines are available.

DATES: The meeting will be held on November 15, 2018, 9:00 a.m. to 5:00 
p.m., EST, and November 16, 2018, 9:00 a.m. to 12:00 p.m., EST.

ADDRESSES: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE, 
Atlanta, Georgia 30329-4027 and teleconference at 800-857-9838, 
passcode: 5325685.

FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of 
Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, 
Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045. Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Time will be available for public comment. 
The public is welcome to submit written comments in advance of the 
meeting. Comments should be submitted in writing by email to the 
contact person listed below. The deadline for receipt of written public 
comment is November 1, 2018. All requests must contain the name, 
address, and organizational affiliation of the speaker, as well as the 
topic being addressed. Written comments should not exceed one single-
spaced typed page in length and delivered in 3 minutes or less. Members 
of the public who wish to provide public comments should plan to attend 
the public comment session at the start time listed. Please note that 
the public comment period may end before the time indicated, following 
the last call for comments. Written comments received in advance of the 
meeting will be included in the official record of the meeting. 
Registration is required to attend in person or on the phone. 
Interested parties must be processed in accordance with established 
federal policies and procedures and may register at www.cdc.gov/hicpac.
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, 
Health and Human Services, regarding (1) the practice of healthcare 
infection prevention and control; (2) strategies for surveillance, 
prevention, and control of infections, antimicrobial resistance, and 
related events in settings where healthcare is provided; and (3) 
periodic updating of CDC guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters to be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare-associated infections. It will 
also include updates from the following HICPAC workgroups: The 
Healthcare Personnel Guideline Workgroup; the National Healthcare 
Safety Network (NHSN) Workgroup; the Neonatal Intensive Care Unit 
(NICU) Guideline Workgroup; and the Products and Practices Workgroup. 
Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-21701 Filed 10-4-18; 8:45 am]
 BILLING CODE 4163-19-P